US Tariffs Fatal for European Pharma

© Ployker - Adobe Stock

Trump's tariff policy is a considerable burden and a break with previous practice

Under the trade agreement concluded between the European Union and the United States at the end of July, exports of pharmaceutical products from Europe to the US will also be subject to a 15 percent tariff in future. Companies and associations expect significant economic losses.

Thorsten Schüller, CHEManager International

Under the trade agreement concluded between the European Union and the United States at the end of July, exports of pharmaceutical products from Europe to the US will also be subject to a 15% tariff in future. For imports from Switzerland—not a member of the EU—the US Administration has even announced a 39% tariff. And for most goods from the UK, tariffs of 10% have been set. Although pharmaceutical products are still exempt from this, significant levies are also looming here. Companies and associations see this as a break with previous practice and expect significant economic losses. How is the industry responding to the new challenges?

This article was published in CHEManager International 3/2025

Read more!
Get the latest news, insightful interviews, in-depth market reports, and expertly researched articles—giving CHEManager International readers a real edge.

To the issue

Read more with free registration

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Sign in or register

Company

Logo:

CHEManager International c/o Wiley-VCH GmbH

Boschstrasse 12
69469 Weinheim
Germany

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.